News - Latest
98 news items
Confirmation of names for influenza strains
The Medicines Evaluation Board (MEB) has confirmed the Dutch translation for the active substances for influenza strains for the ...
PSUR Repository has entered 'switch-on' phase
The PSUR-repository is the single, central platform to be used by all regulatory authorities and pharmaceutical companies in the ...
International cooperation of Medicines Authorities in the fight against Zika virus disease
Medicines agencies worldwide - united in the “International Coalition of Medicines Regulatory Authorities (ICMRA)” - have joined ...
No variation for change of QPPV and/or PSMF location
As of 1 February 2016, a change in the “Qualified Person responsible for PharmacoVigilance” (QPPV) or the location of the ...
Amendment of policy for usage patents and publication
The Medicines Evaluation Board (MEB) wants to continue publishing the complete SmPC and package leaflet of generic medicinal ...
Kees van Nieuwkoop sworn in as new MEB member today
Dr C. (Kees) van Nieuwkoop was sworn in today as new member of the Medicines Evaluation Board (MEB).
New policy on national implementation of DHPCs
The Medicines Evaluation Board (MEB) has adopted a policy for the national implementation of Direct Health Care Professional ...
Shelf life of over-the-counter medicinal products after opening
There is currently a lot of media attention for the listing of the shelf life after opening of over-the-counter medicinal ...
Patient involvement in drug decisions
On 1 October 2015, representatives of approximately 30 patient organisations joined the Medicines Evaluation Board (MEB) to ...